Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Oyster Point Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 60 | 2 | 53 | −5 |
| Shares | 20.0M | 19.0K | 17.0M | −3.06M (−15.3%) |
| Value | $112.6M | $107.0K | $189.4M | +$76.9M (+68.4%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Oyster Point Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Westchester Capital Management, LLC | 655,044 | $7.32M | 0.21% |
| Gabelli Funds LLC | 651,051 | $7.27M | 0.06% |
| MMCAP International Inc. SPC | 515,491 | $5.76M | 0.58% |
| Man Group plc | 319,524 | $3.57M | 0.01% |
| Chicago Capital Management, LLC | 212,234 | $2.37M | 2.15% |
| Yakira Capital Management, Inc. | 174,763 | $1.95M | 0.40% |
| Gabelli & Co Investment Advisers, Inc. | 170,250 | $1.90M | 0.41% |
| Deltec Asset Management LLC | 162,042 | $1.81M | 0.52% |
| Gamco Investors, Inc. Et Al | 158,815 | $1.77M | 0.02% |
| Bluefin Capital Management, LLC | 45,000 | $502.6K | 0.09% |
| Prelude Capital Management, LLC | 44,115 | $492.8K | 0.03% |
| Endurant Capital Management LP | 19,927 | $222.6K | 0.09% |
| Equitec Proprietary Markets, LLC | 17,266 | $192.9K | 0.11% |
| Guggenheim Capital LLC | 12,816 | $143.2K | 0.00% |
| Crystalline Management Inc. | 11,421 | $127.6K | 0.06% |
| Squarepoint Ops LLC | 11,375 | $127.1K | 0.00% |
| Freedom Wealth Alliance, LLC | 1,921 | $21.5K | 0.03% |
| Belpointe Asset Management LLC | 10 | $112 | 0.00% |
Sold out (23)
Institutions that held Oyster Point Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,805,387 | $10.1M |
| Paradigm Biocapital Advisors LP | 1,648,316 | $9.26M |
| Telemark Asset Management, LLC | 777,026 | $4.37M |
| Cowen and Company, LLC | 509,794 | $2.87M |
| KPCB XIV Associates, LLC | 367,987 | $2.07M |
| Barclays PLC | 77,427 | $435.0K |
| State Street Corp | 48,934 | $275.0K |
| Walleye Capital LLC | 20,182 | $113.0K |
| Ergoteles LLC | 14,172 | $80.0K |
| Qube Research & Technologies Ltd | 14,248 | $80.0K |
| HarbourVest Partners LLC | 12,560 | $71.0K |
| Kestra Advisory Services, LLC | 12,100 | $68.0K |
| Bank of New York Mellon Corp | 10,834 | $61.0K |
| Cherry Creek Investment Advisors, Inc. | 10,000 | $56.0K |
| Leonteq Securities AG | 7,000 | $39.3K |
| Rockefeller Capital Management L.P. | 4,000 | $22.0K |
| Cubist Systematic Strategies, LLC | 2,761 | $16.0K |
| GPS Wealth Strategies Group, LLC | 2,052 | $12.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,697 | $10.0K |
| Gibson Wealth Advisors LLC | 1,100 | $6.00K |
| China Universal Asset Management Co., Ltd. | 251 | $1.00K |
| Daiwa Securities Group Inc. | 76 | $0 |
| TCI Wealth Advisors, Inc. | 50 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Oyster Point Pharma, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACG Wealth | 10,500 | $59.0K |
| ACT Capital Management, LLC | 8,500 | $48.0K |